296
Views
66
CrossRef citations to date
0
Altmetric
Review

Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs

, , , , , & show all
Pages 983-998 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Liliana Rodrigues, Pedro Cravo & Miguel Viveiros. (2020) Efflux pump inhibitors as a promising adjunct therapy against drug resistant tuberculosis: a new strategy to revisit mycobacterial targets and repurpose old drugs. Expert Review of Anti-infective Therapy 18:8, pages 741-757.
Read now
Shasank S. Swain, Divakar Sharma, Tahziba Hussain & Sanghamitra Pati. (2020) Molecular mechanisms of underlying genetic factors and associated mutations for drug resistance in Mycobacterium tuberculosis. Emerging Microbes & Infections 9:1, pages 1651-1663.
Read now
Davide Benedetto Tiz, Danijel Kikelj & Nace Zidar. (2018) Overcoming problems of poor drug penetration into bacteria: challenges and strategies for medicinal chemists. Expert Opinion on Drug Discovery 13:6, pages 497-507.
Read now
Carina Beatrice Vibe, Federico Fenaroli, David Pires, Steven Ray Wilson, Vanya Bogoeva, Raja Kalluru, Martin Speth, Elsa Anes, Gareth Griffiths & Jon Hildahl. (2016) Thioridazine in PLGA nanoparticles reduces toxicity and improves rifampicin therapy against mycobacterial infection in zebrafish. Nanotoxicology 10:6, pages 680-688.
Read now
Liem Nguyen & Michael R Jacobs. (2012) Counterattacking drug-resistant tuberculosis: molecular strategies and future directions. Expert Review of Anti-infective Therapy 10:9, pages 959-961.
Read now

Articles from other publishers (61)

Christy Rosaline Nirmal, Sam Ebenezer Rajadas, Mahizhaveni Balasubramanian, Sucharitha Kannappan Mohanvel, Muthu Sankar Aathi, Saravanan Munishankar, Naresh Babu Chilamakuru, Kannan Thiruvenkadam, Ajith Kumar Pandiya Raj, Ramalingam Paraman & Azger Dusthackeer. (2023) Myoinositol and methyl stearate increases rifampicin susceptibility among drug‐resistant Mycobacterium tuberculosis expressing Rv1819c . Chemical Biology & Drug Design 101:4, pages 883-895.
Crossref
Roslyn Dermody, Farizah Ali, John Popovich, Shaojiang Chen, Dong-Kyun Seo & Shelley E. Haydel. (2022) Modified aluminosilicates display antibacterial activity against nontuberculous mycobacteria and adsorb mycolactone and Mycobacterium ulcerans in vitro. Frontiers in Tropical Diseases 3.
Crossref
N. I. Akimova, O. B. Bekker & V. N. Danilenko. (2022) Functional Significance of Mycolicibacterium smegmatis Toxin–Antitoxin Module in Resistance to Antibiotics and Oxidative Stress. Russian Journal of Genetics 58:5, pages 547-557.
Crossref
Manzoor Ahmad Mir, Shariqa Aisha, Hafsa Qadri, Ulfat Jan, Abrar Yousuf & Nusrat Jan. 2022. Human Pathogenic Microbes. Human Pathogenic Microbes 31 52 .
Lijun Song, Romain Merceron, Fabian Hulpia, Ainhoa Lucía, Begoña Gracia, Yanlin Jian, Martijn D.P. Risseeuw, Toon Verstraelen, Paul Cos, José A. Aínsa, Helena I. Boshoff, Hélène Munier-Lehmann, Savvas N. Savvides & Serge Van Calenbergh. (2021) Structure-aided optimization of non-nucleoside M. tuberculosis thymidylate kinase inhibitors. European Journal of Medicinal Chemistry 225, pages 113784.
Crossref
Eloísa Gibin SampironGiovana Ferreira CostacurtaLeonora Lacerda CalsavaraVanessa Pietrowski Baldin, Gabrielle Vaz da SilvaVanessa Guimarães Alves OlherLincoln Herholz FerrarettoKatiany Rizzieri Caleffi-FerraciolliRosilene Fressatti CardosoVera Lucia Dias SiqueiraFábio VandresenRegiane Bertin de Lima Scodro. (2021) In Vitro and In Silico Evaluations of Anti- Mycobacterium tuberculosis Activity of Benzohydrazones Compounds . Microbial Drug Resistance 27:11, pages 1564-1577.
Crossref
Felix Heinrich, Faisal Ramzan, Abirami Rajavel, Armin Otto Schmitt & Mehmet Gültas. (2021) MIDESP: Mutual Information-Based Detection of Epistatic SNP Pairs for Qualitative and Quantitative Phenotypes. Biology 10:9, pages 921.
Crossref
Katarina Šimunović, Julia Solnier, Fabian Alperth, Olaf Kunert, Sonja Smole Smole Možina & Franz Bucar. (2021) Efflux Pump Inhibition and Resistance Modulation in Mycobacterium smegmatis by Peucedanum ostruthium and Its Coumarins. Antibiotics 10:9, pages 1075.
Crossref
Erika Kapp, Jacques Joubert, Samantha L. Sampson, Digby F. Warner, Ronnett Seldon, Audrey Jordaan, Margaretha de Vos, Rajan Sharma & Sarel F. Malan. (2021) Antimycobacterial Activity, Synergism, and Mechanism of Action Evaluation of Novel Polycyclic Amines against Mycobacterium tuberculosis. Advances in Pharmacological and Pharmaceutical Sciences 2021, pages 1-8.
Crossref
Priscila Cristina Bartolomeu Halicki, Júlia Silveira Vianna, Nilo Zanatta, Valquiria Pereira de Andrade, Mariana de Oliveira, Malu Mateus, Marcos Vinicius da Silva, Virmondes RodriguesJúniorJúnior, Daniela Fernandes Ramos & Pedro Eduardo Almeida da Silva. (2021) 2,2,2-trifluoro-1-(1,4,5,6-tetrahydropyridin-3-yl)ethanone derivative as efflux pump inhibitor in Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry Letters 42, pages 128088.
Crossref
Santasree Sarma Biswas, Rene Barbie Browne, Vedant Vikrom Borah & Jayanti Datta Roy. (2021) In Silico Approach for Phytocompound-Based Drug Designing to Fight Efflux Pump-Mediated Multidrug-Resistant Mycobacterium tuberculosis. Applied Biochemistry and Biotechnology 193:6, pages 1757-1779.
Crossref
Irene Rossi, Ruggero Bettini & Francesca Buttini. (2021) Resistant Tuberculosis: the Latest Advancements of Second-line Antibiotic Inhalation Products. Current Pharmaceutical Design 27:12, pages 1436-1452.
Crossref
Saptarshi Ghosh, Karishma Berta Cotta, Aniket A. Hande, Moneesha Fernandes & Sarika Mehra. (2021) PNA-mediated efflux inhibition as a therapeutic strategy towards overcoming drug resistance in Mycobacterium smegmatis. Microbial Pathogenesis 151, pages 104737.
Crossref
Liliana Rodrigues, José A. Aínsa & Miguel Viveiros. 2021. Mycobacteria Protocols. Mycobacteria Protocols 231 245 .
Laura Rindi. (2020) Efflux Pump Inhibitors against Nontuberculous Mycobacteria. International Journal of Molecular Sciences 21:12, pages 4191.
Crossref
Manaf AlMatar, Işıl Var, Begüm Kayar & Fatih Köksal. (2020) Differential Expression of Resistant and Efflux Pump Genes in MDR-TB Isolates. Endocrine, Metabolic & Immune Disorders - Drug Targets 20:2, pages 271-287.
Crossref
Julia Solnier, Liam Martin, Sanjib Bhakta & Franz Bucar. (2020) Flavonoids as Novel Efflux Pump Inhibitors and Antimicrobials Against Both Environmental and Pathogenic Intracellular Mycobacterial Species. Molecules 25:3, pages 734.
Crossref
Ramandeep Singh, Pradeep Kumar & Kapil Tahlan. 2020. Drug Discovery Targeting Drug-Resistant Bacteria. Drug Discovery Targeting Drug-Resistant Bacteria 139 170 .
Hasan Ghajavand, Mansour Kargarpour Kamakoli, Sharareh Khanipour, Shahin Pourazar Dizaji, Morteza Masoumi, Fatemeh Rahimi Jamnani, Abolfazl Fateh, Mehdi Yaseri, Seyed Davar Siadat & Farzam Vaziri. (2019) Scrutinizing the drug resistance mechanism of multi- and extensively-drug resistant Mycobacterium tuberculosis: mutations versus efflux pumps. Antimicrobial Resistance & Infection Control 8:1.
Crossref
Mohamed Sabry Abd Elraheam Elsayed, Tamer Roshdey, Ahmed Salah, Reda Tarabees, Gamal Younis & Doaa Eldeep. (2019) Phenotypic and genotypic methods for identification of slime layer production, efflux pump activity, and antimicrobial resistance genes as potential causes of the antimicrobial resistance of some mastitis pathogens from farms in Menoufia, Egypt. Molecular Biology Reports 46:6, pages 6533-6546.
Crossref
Andria Papageorgiou, Angeliki-Sofia Foscolos, Ioannis P Papanastasiou, Marilena Vlachou, Angeliki Siamidi, Anthony Vocat, Stewart T Cole, Tahsin F Kellici, Thomas Mavromoustakos & Andrew Tsotinis. (2019) Synthesis, biology, computational studies and in vitro controlled release of new isoniazid-based adamantane derivatives . Future Medicinal Chemistry 11:21, pages 2779-2802.
Crossref
Hellen Aparecida Silva Ponte, Maria Islaine de Oliveira Lima, Edeltrudes de Oliveira Lima & Fillipe de Oliveira Pereira. (2019) Linalool modulates dermatophyte susceptibility to azole drugs. Medical Mycology.
Crossref
Joāo Luís Rheingantz Scaini, Alex Dias Camargo, Vinicius Rosa Seus, Andrea von Groll, Adriano Velasque Werhli, Pedro Eduardo Almeida da Silva & Karina dos Santos Machado. (2019) Molecular modelling and competitive inhibition of a Mycobacterium tuberculosis multidrug-resistance efflux pump. Journal of Molecular Graphics and Modelling 87, pages 98-108.
Crossref
Virginia Meikle, Ann-Kristin Mossberg, Avishek Mitra, Anders P. Hakansson & Michael Niederweis. (2019) A Protein Complex from Human Milk Enhances the Activity of Antibiotics and Drugs against Mycobacterium tuberculosis . Antimicrobial Agents and Chemotherapy 63:2.
Crossref
Marco Pieroni. 2019. Medicinal Chemistry Approaches to Tuberculosis and Trypanosomiasis. Medicinal Chemistry Approaches to Tuberculosis and Trypanosomiasis 27 69 .
Maikel Boot & E. Hesper Rego. 2019. Persister Cells and Infectious Disease. Persister Cells and Infectious Disease 247 272 .
Diana Machado, Emmanuel Lecorche, Faiza Mougari, Emmanuelle Cambau & Miguel Viveiros. (2018) Insights on Mycobacterium leprae Efflux Pumps and Their Implications in Drug Resistance and Virulence. Frontiers in Microbiology 9.
Crossref
K. V. Shur, O. B. Bekker, M. V. Zaichikova, D. A. Maslov, N. I. Akimova, N. V. Zakharevich, M. S. Chekalina & V. N. Danilenko. (2018) Genetic Aspects of Drug Resistance and Virulence in Mycobacterium tuberculosis. Russian Journal of Genetics 54:12, pages 1385-1396.
Crossref
Xingchen Zhao, Xudong Tang, Na Guo, Yanan An, Xiangrong Chen, Ce Shi, Chao Wang, Yan Li, Shulin Li, Hongyue Xu, Mingyuan Liu, Yang Wang & Lu Yu. (2018) Biochanin a Enhances the Defense Against Salmonella enterica Infection Through AMPK/ULK1/mTOR-Mediated Autophagy and Extracellular Traps and Reversing SPI-1-Dependent Macrophage (MΦ) M2 Polarization. Frontiers in Cellular and Infection Microbiology 8.
Crossref
Diana Machado, Miriam Girardini, Miguel Viveiros & Marco Pieroni. (2018) Challenging the Drug-Likeness Dogma for New Drug Discovery in Tuberculosis. Frontiers in Microbiology 9.
Crossref
Pedro Henrique Canezin, Katiany Rizzieri Caleffi-Ferracioli, Regiane Bertin de Lima Scodro, Vera Lúcia Dias Siqueira, Fernando Rogério Pavan, Isabella Letícia Esteves Barros & Rosilene Fressatti Cardoso. (2018) Intramacrophage Mycobacterium tuberculosis efflux pump gene regulation after rifampicin and verapamil exposure. Journal of Antimicrobial Chemotherapy 73:7, pages 1770-1776.
Crossref
Diana Machado, João Perdigão, Isabel Portugal, Marco Pieroni, Pedro Silva, Isabel Couto & Miguel Viveiros. (2018) Efflux Activity Differentially Modulates the Levels of Isoniazid and Rifampicin Resistance among Multidrug Resistant and Monoresistant Mycobacterium tuberculosis Strains. Antibiotics 7:1, pages 18.
Crossref
Cynthia A. Danquah, Eleftheria Kakagianni, Proma Khondkar, Arundhati Maitra, Mukhlesur Rahman, Dimitrios Evangelopoulos, Timothy D. McHugh, Paul Stapleton, John Malkinson, Sanjib Bhakta & Simon Gibbons. (2018) Analogues of Disulfides from Allium stipitatum Demonstrate Potent Anti-tubercular Activities through Drug Efflux Pump and Biofilm Inhibition. Scientific Reports 8:1.
Crossref
Elisa Azzali, Diana Machado, Amit Kaushik, Federica Vacondio, Sara Flisi, Clotilde Silvia Cabassi, Gyanu Lamichhane, Miguel Viveiros, Gabriele Costantino & Marco Pieroni. (2017) Substituted N -Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery . Journal of Medicinal Chemistry 60:16, pages 7108-7122.
Crossref
Diana Machado, Tatiane S. Coelho, João Perdigão, Catarina Pereira, Isabel Couto, Isabel Portugal, Raquel De Abreu Maschmann, Daniela F. Ramos, Andrea von Groll, Maria L. R. Rossetti, Pedro A. Silva & Miguel Viveiros. (2017) Interplay between Mutations and Efflux in Drug Resistant Clinical Isolates of Mycobacterium tuberculosis. Frontiers in Microbiology 8.
Crossref
Liliana Rodrigues, Tanya Parish, Meenakshi Balganesh & José A. Ainsa. (2017) Antituberculosis drugs: reducing efflux = increasing activity. Drug Discovery Today 22:3, pages 592-599.
Crossref
Leonard Amaral & Miguel Viveiros. (2017) Thioridazine: A Non-Antibiotic Drug Highly Effective, in Combination with First Line Anti-Tuberculosis Drugs, against Any Form of Antibiotic Resistance of Mycobacterium tuberculosis Due to Its Multi-Mechanisms of Action. Antibiotics 6:1, pages 3.
Crossref
Nitendra Kumar, Bhaskar Das & Sanjukta Patra. 2017. Antimicrobial Nanoarchitectonics. Antimicrobial Nanoarchitectonics 261 278 .
Sofia Santos CostaElizeth LopesElisa AzzaliDiana MachadoTatiane CoelhoPedro Eduardo Almeida da SilvaMiguel ViveirosMarco PieroniIsabel Couto. (2016) An Experimental Model for the Rapid Screening of Compounds with Potential Use Against Mycobacteria. ASSAY and Drug Development Technologies 14:9, pages 524-534.
Crossref
Malkeet Kumar, Kawaljit Singh, Krupa Naran, Fahreta Hamzabegovic, Daniel F. Hoft, Digby F. Warner, Peter Ruminski, Getahun Abate & Kelly Chibale. (2016) Design, Synthesis, and Evaluation of Novel Hybrid Efflux Pump Inhibitors for Use against Mycobacterium tuberculosis . ACS Infectious Diseases 2:10, pages 714-725.
Crossref
Liem Nguyen. (2016) Antibiotic resistance mechanisms in M. tuberculosis: an update. Archives of Toxicology 90:7, pages 1585-1604.
Crossref
Jeroen de Keijzer, Arnout Mulder, Petra E. W. de Haas, Arnoud H. de Ru, Evy M. Heerkens, Leonard Amaral, Dick van Soolingen & Peter A. van Veelen. (2016) Thioridazine Alters the Cell-Envelope Permeability of Mycobacterium tuberculosis . Journal of Proteome Research 15:6, pages 1776-1786.
Crossref
Fernando Corona, Paula Blanco, Manuel Alcalde-Rico, Sara Hernando-Amado, Felipe Lira, Alejandra Bernardini, María B Sánchez & José L Martínez. (2016) The analysis of the antibiotic resistome offers new opportunities for therapeutic intervention. Future Medicinal Chemistry 8:10, pages 1133-1151.
Crossref
Andromeda Gomez, Núria Andreu, Mario Ferrer-Navarro, Daniel Yero & Isidre Gibert. (2016) Triclosan-induced genes Rv1686c-Rv1687c and Rv3161c are not involved in triclosan resistance in Mycobacterium tuberculosis. Scientific Reports 6:1.
Crossref
Katiany R. Caleffi-Ferracioli, Renata Claro R. Amaral, Fernanda O. Demitto, Flaviane G. Maltempe, Pedro Henrique Canezin, Regiane B.L. Scodro, Celso V. Nakamura, Clarice Queico F. Leite, Vera Lúcia D. Siqueira & Rosilene F. Cardoso. (2016) Morphological changes and differentially expressed efflux pump genes in Mycobacterium tuberculosis exposed to a rifampicin and verapamil combination. Tuberculosis 97, pages 65-72.
Crossref
Diana Machado, David Pires, João Perdigão, Isabel Couto, Isabel Portugal, Marta Martins, Leonard Amaral, Elsa Anes & Miguel Viveiros. (2016) Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis. PLOS ONE 11:2, pages e0149326.
Crossref
Caroline M. Pule, Samantha L. Sampson, Robin M. Warren, Philippa A. Black, Paul D. van Helden, Tommie C. Victor & Gail E. Louw. (2016) Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy. Journal of Antimicrobial Chemotherapy 71:1, pages 17-26.
Crossref
Jeroen A. Rombouts, Richard M. P. Veenboer, Cristina Villellas, Ping Lu, Andreas W. Ehlers, Koen Andries, Anil Koul, Holger Lill, Eelco Ruijter, Romano V. A. Orru, Koop Lammertsma, Dirk Bald & J. Chris Slootweg. (2016) Synthesis, characterization and biological activity of fluorescently labeled bedaquiline analogues. RSC Advances 6:110, pages 108708-108716.
Crossref
Pedro Eduardo Almeida da Silva, Diana Machado, Daniela Ramos, Isabel Couto, Andrea Von Groll & Miguel Viveiros. 2016. Efflux-Mediated Antimicrobial Resistance in Bacteria. Efflux-Mediated Antimicrobial Resistance in Bacteria 527 559 .
Giovanna Poce & Mariangela Biava. (2015) Overcoming drug resistance for tuberculosis. Future Microbiology 10:11, pages 1735-1741.
Crossref
Marco Pieroni, Diana Machado, Elisa Azzali, Sofia Santos Costa, Isabel Couto, Gabriele Costantino & Miguel Viveiros. (2015) Rational Design and Synthesis of Thioridazine Analogues as Enhancers of the Antituberculosis Therapy. Journal of Medicinal Chemistry 58:15, pages 5842-5853.
Crossref
Aurélien Chollet, Giorgia Mori, Christophe Menendez, Frédéric Rodriguez, Isabelle Fabing, Maria Rosalia Pasca, Jan Madacki, Jana Korduláková, Patricia Constant, Annaïk Quémard, Vania Bernardes-Génisson, Christian Lherbet & Michel Baltas. (2015) Design, synthesis and evaluation of new GEQ derivatives as inhibitors of InhA enzyme and Mycobacterium tuberculosis growth. European Journal of Medicinal Chemistry 101, pages 218-235.
Crossref
Rebeca Bailo, Apoorva Bhatt & José A. Aínsa. (2015) Lipid transport in Mycobacterium tuberculosis and its implications in virulence and drug development. Biochemical Pharmacology 96:3, pages 159-167.
Crossref
Corey L. Compton, Daniel W. Carney, Patrice V. Groomes & Jason K. Sello. (2014) Fragment-Based Strategy for Investigating and Suppressing the Efflux of Bioactive Small Molecules. ACS Infectious Diseases 1:1, pages 53-58.
Crossref
Liliana Rodrigues, Miguel Viveiros & José A. Aínsa. 2015. Mycobacteria Protocols. Mycobacteria Protocols 227 239 .
Ana Nobre, Susana Alarico, Ana Maranha, Vitor Mendes & Nuno Empadinhas. (2014) The molecular biology of mycobacterial trehalose in the quest for advanced tuberculosis therapies. Microbiology 160:8, pages 1547-1570.
Crossref
Filomena Martins, Susana Santos, Cristina Ventura, Ruben Elvas-Leitão, Lídia Santos, Susana Vitorino, Marina Reis, Vanessa Miranda, Henrique F. Correia, João Aires-de-Sousa, Vasyl Kovalishyn, Diogo A.R.S. Latino, Jorge Ramos & Miguel Viveiros. (2014) Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity. European Journal of Medicinal Chemistry 81, pages 119-138.
Crossref
Miguel Viveiros & Marco Pieroni. (2014) Spectinamides: a challenge, a proof, and a suggestion. Trends in Microbiology 22:4, pages 170-171.
Crossref
Sujata Dastidar, Jette Kristiansen, Joseph Molnar & Leonard Amaral. (2013) Role of Phenothiazines and Structurally Similar Compounds of Plant Origin in the Fight against Infections by Drug Resistant Bacteria. Antibiotics 2:1, pages 58-72.
Crossref
Liliana Rodrigues, Cristina Villellas, Rebeca Bailo, Miguel Viveiros & José A. Aínsa. (2013) Role of the Mmr Efflux Pump in Drug Resistance in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 57:2, pages 751-757.
Crossref
Tasha Smith, Kerstin A. Wolff & Liem Nguyen. 2013. Pathogenesis of Mycobacterium tuberculosis and its Interaction with the Host Organism. Pathogenesis of Mycobacterium tuberculosis and its Interaction with the Host Organism 53 80 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.